Abstract
Background
Methods
Results
Conclusion
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryReferences
- Cancer statistics, 2018.CA Cancer J Clin. 2018; 68: 7-30
- Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.Cancer Res. 2014; 74: 2913-2921
- Current state of surgical management of pancreatic cancer.Cancers (Basel). 2011; 3: 1253-1273
- Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial.Ann Surg. 2018; 268: 215-222
- A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact.Eur J Cancer. 2021; 159: 215-223
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).Lancet. 2016; 388: 248-257
- FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer.N Engl J Med. 2018; 379: 2395-2406
- Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.Ann Surg. 2014; 260: 372-377
- Postoperative infectious complications worsen long-term survival after curative-intent resection for hepatocellular carcinoma.Ann Surg Oncol. 2022; 29: 315-324
- Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.Br J Surg. 2019; 106: 1228-1236
- The negative survival impact of infectious complications after surgery is canceled out by the response of neoadjuvant chemotherapy in patients with esophageal cancer.Ann Surg Oncol. 2018; 25: 2034-2043
- Impact of postoperative complication and completion of multimodality therapy on survival in patients undergoing gastrectomy for advanced gastric cancer.J Am Coll Surg. 2020; 230: 912-924
- Postoperative infection after colorectal surgery: subanalysis of data from the 2015 Japan Postoperative Infectious Complications Survey.J Nippon Med Sch. 2020; 87: 204-210
- Anastomotic leakage is associated with impaired overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.Ann Surg Oncol. 2015; 22: 2059-2067
- Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials.Cancer Med. 2017; 6: 1573-1580
- CDC definitions for nosocomial infections, 1988.Am J Infect Control. 1988; 16: 128-140
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after.Surgery. 2017; 161: 584-591
- A systematic review of risk factors associated with surgical site infections among surgical patients.PLoS One. 2013; 8e83743
- Patient-related risk factors for surgical site infection following eight types of gastrointestinal surgery.J Hosp Infect. 2016; 93 (3473–54)
- A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.J Am Coll Surg. 2013; 216: 1-14
- Impact of postoperative remote infection on length of stay and medical costs in hospitals in Japan.Surg Today. 2021; 51: 212-218
- Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection.Cancer Chemother Pharmacol. 2013; 71: 419-429
Article info
Publication history
Footnotes
Conception/design (K. Okada, K. Uemura, S. Akagi, T. Inoue, M. Kobayashi, H. Shiomi H, A. Matsuda, M. Watanabe, K. Tanemoto, and H. Maruyama); data acquisition (all authors); data interpretation (all authors); critical revisions (all authors); and final approval (all authors). All individuals claiming authorship meet all of the following 3 conditions: (1) authors made substantial contributions to conception and design and/or acquisition of data and/or analysis and interpretation of data; (2) authors participated in drafting the article or revising it critically for important intellectual content; and (3) authors gave final approval of the version to be published.